MoatScan.ai
Vertex Pharmaceuticals Incorporated
VRTX · Moat type: REGULIERUNG
GESCHÄFTSMODELL
Vertex Pharmaceuticals develops and markets patent-protected medications for treating rare genetic diseases—particularly cystic fibrosis (CF)—and generates revenue almost exclusively through global sales of these prescription-only specialty pharmaceuticals.
View full analysis →
🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.
Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.